Metraipolis › archive › dc_050cbe21ecb5

Nanomaterial-enabled delivery of plant-derived bioactive metabolites for diabetic retinopathy: from evidence appraisal to preclinical translation — Europe PMC PMID:42434121

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42434121
DOI: 10.3389/fphar.2026.1809139
License (as archived): solo-consultazione
Archived: 2026-10-31T08:41:13.497Z
SHA-256 of the archived text: 0adc5b095d734fb81baccbcbee3890946060c03a1cbc36d9cbf613c3a1bc8e00
Stable URL of this page: https://metraipolis.com/documento/dc_050cbe21ecb5

How to cite

Nanomaterial-enabled delivery of plant-derived bioactive metabolites for diabetic retinopathy: from evidence appraisal to preclinical translation — Europe PMC PMID:42434121 — Europe PMC (en), https://europepmc.org/article/MED/42434121 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_050cbe21ecb5 (Metraipolis archive dc_050cbe21ecb5, sha256 0adc5b095d734fb81baccbcbee3890946060c03a1cbc36d9cbf613c3a1bc8e00)

BibTeX

@misc{dc050cbe21ecb5,
  title = {Nanomaterial-enabled delivery of plant-derived bioactive metabolites for diabetic retinopathy: from evidence appraisal to preclinical translation — Europe PMC PMID:42434121},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42434121},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_050cbe21ecb5; sha256 0adc5b095d734fb81baccbcbee3890946060c03a1cbc36d9cbf613c3a1bc8e00},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42434121. Agents can read the archived copy with the MCP tool read_document.